TELA · TELA Bio Inc. Common Stock
View on chartInsiders & Stakes
| EW HEALTHCARE PARTNERS FUND 2, L.P. | ▲ Buy | Open Market | 7,714,709 Shares held | 11/17/2025 | View profile |
| ORBIMED ADVISORS LLC Director | ▼ Sell | Open Market | 2,407,242 Shares held | 7/2/2024 | View profile |
| Antony Koblish Chief Executive Officer | ▼ Sell | Tax Withholding | 586,210 Shares held | 2/24/2026 | View profile |
| Heather C. Getz EVP & Chief Financial Officer | ▲ Buy | Open Market | 532,500 Shares held | 8/17/2026 | View profile |
| Roberto Cuca COO and CFO | ▼ Sell | Tax Withholding | 257,377 Shares held | 2/23/2026 | View profile |
| Jeffrey Blizard Director | ▲ Buy | Grant | 205,125 Shares held | 2/20/2026 | View profile |
| Joseph H. Capper Director | ▲ Buy | Open Market | 179,827 Shares held | 9/17/2026 | View profile |
| Paul Talmo Chief Strategic Officer | ▼ Sell | Tax Withholding | 173,436 Shares held | 2/23/2026 | View profile |
| Gregory A. Firestone Chief Business Officer | ▼ Sell | Tax Withholding | 139,307 Shares held | 2/23/2026 | View profile |
| Opaleye Management Inc. 10% Owner | ▲ Buy | Open Market | 124,813 Shares held | 11/3/2022 | View profile |
| Megan Smeykal Chief Accounting Officer | ▼ Sell | Tax Withholding | 66,873 Shares held | 2/23/2026 | View profile |
| Murphy Peter C. Chief Commercial Officer | ▼ Sell | Tax Withholding | 48,129 Shares held | 3/31/2024 | View profile |
| William J. Plovanic | ▲ Buy | Grant | 44,530 Shares held | 7/15/2026 | View profile |
| Greenhalgh Ellis Skott Chief Technology Officer | ▼ Sell | Tax Withholding | 27,826 Shares held | 2/24/2022 | View profile |
| Betty Jo Rocchio | ▲ Buy | Grant | 23,600 Shares held | 6/9/2026 | View profile |
| Guido J. Neels Director | ▲ Buy | Grant | 23,600 Shares held | 6/9/2026 | View profile |
| Paul Thomas Director | ▲ Buy | Grant | 23,600 Shares held | 6/9/2026 | View profile |
| Guy P. Nohra Director | ▲ Buy | Grant | 23,600 Shares held | 6/9/2026 | View profile |
| Vincent J. Burgess Director | ▲ Buy | Grant | 23,330 Shares held | 5/28/2025 | View profile |
| Douglas G. Evans Director | ▲ Buy | Grant | 18,470 Shares held | 5/28/2025 | View profile |
| Federica F. O'Brien Director | ▲ Buy | Grant | 18,470 Shares held | 5/28/2025 | View profile |
| Kurt Azarbarzin Director | ▲ Buy | Grant | 18,470 Shares held | 5/28/2025 | View profile |
| Lisa N. Colleran Director | ▲ Buy | Grant | 18,470 Shares held | 5/28/2025 | View profile |
| Nosenzo John CHIEF COMMERCIAL OFFICER | ▲ Buy | Grant | 6,270 Shares held | 6/1/2023 | View profile |
| Quaker BioVentures II LP 10% Owner | ▼ Sell | Other | 0 Shares held | 6/2/2022 | View profile |
Transaction History
| Joseph H. Capper | ▲ Buy | Open Market | 25,000 | $31K | 9/17/2026 |
| Joseph H. Capper | ▲ Buy | Open Market | 50,000 | $58K | 9/16/2026 |
| Joseph H. Capper | ▲ Buy | Open Market | 50,000 | $53K | 9/15/2026 |
| Joseph H. Capper | ▲ Buy | Open Market | 25,000 | $26K | 9/14/2026 |
| Heather C. Getz | ▲ Buy | Open Market | 12,500 | $8K | 8/17/2026 |
| Heather C. Getz | ▲ Buy | Open Market | 15,000 | $10K | 8/14/2026 |
| Heather C. Getz | ▲ Buy | Grant | 500,000 | $0 | 8/3/2026 |
| William J. Plovanic | ▲ Buy | Grant | 20,930 | $16K | 7/15/2026 |
| Joseph H. Capper | ▲ Buy | Grant | 6,227 | $5K | 7/15/2026 |
| Joseph H. Capper | ▲ Buy | Grant | 11,675 | $0 | 6/9/2026 |
| William J. Plovanic | ▲ Buy | Grant | 11,675 | $0 | 6/9/2026 |
| Guy P. Nohra | ▲ Buy | Grant | 11,925 | $0 | 6/9/2026 |
| Guy P. Nohra | ▲ Buy | Grant | 11,675 | $0 | 6/9/2026 |
| Betty Jo Rocchio | ▲ Buy | Grant | 11,675 | $0 | 6/9/2026 |
| Joseph H. Capper | ▲ Buy | Grant | 11,925 | $0 | 6/9/2026 |
| Guido J. Neels | ▲ Buy | Grant | 11,925 | $0 | 6/9/2026 |
| Guido J. Neels | ▲ Buy | Grant | 11,675 | $0 | 6/9/2026 |
| Paul Thomas | ▲ Buy | Grant | 11,925 | $0 | 6/9/2026 |
| Paul Thomas | ▲ Buy | Grant | 11,675 | $0 | 6/9/2026 |
| Antony Koblish | ▼ Sell | Tax Withholding | 3,900 | $3K | 2/24/2026 |
| Antony Koblish | ▼ Sell | Tax Withholding | 11,631 | $9K | 2/23/2026 |
| Gregory A. Firestone | ▼ Sell | Tax Withholding | 1,352 | $1K | 2/23/2026 |
| Paul Talmo | ▼ Sell | Tax Withholding | 4,061 | $3K | 2/23/2026 |
| Roberto Cuca | ▼ Sell | Tax Withholding | 5,234 | $4K | 2/23/2026 |
| Megan Smeykal | ▼ Sell | Tax Withholding | 423 | $324 | 2/23/2026 |
| Antony Koblish | ▼ Sell | Tax Withholding | 12,494 | $9K | 2/21/2026 |
| Gregory A. Firestone | ▼ Sell | Tax Withholding | 4,189 | $3K | 2/21/2026 |
| Paul Talmo | ▼ Sell | Tax Withholding | 3,385 | $2K | 2/21/2026 |
| Roberto Cuca | ▼ Sell | Tax Withholding | 4,780 | $3K | 2/21/2026 |
| Megan Smeykal | ▼ Sell | Tax Withholding | 1,590 | $1K | 2/21/2026 |
| Antony Koblish | ▲ Buy | Grant | 176,000 | $0 | 2/20/2026 |
| Gregory A. Firestone | ▲ Buy | Grant | 37,000 | $0 | 2/20/2026 |
| Paul Talmo | ▲ Buy | Grant | 57,000 | $0 | 2/20/2026 |
| Roberto Cuca | ▲ Buy | Grant | 57,000 | $0 | 2/20/2026 |
| Jeffrey Blizard | ▲ Buy | Grant | 86,000 | $0 | 2/20/2026 |
| Megan Smeykal | ▼ Sell | Tax Withholding | 795 | $632 | 2/19/2026 |
| Megan Smeykal | ▲ Buy | Grant | 32,850 | $0 | 2/18/2026 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | ▲ Buy | Open Market | 3,604,000 | $4.0M | 11/17/2025 |
| William J. Plovanic | ▲ Buy | Grant | 11,925 | $0 | 10/31/2025 |
| Betty Jo Rocchio | ▲ Buy | Grant | 11,925 | $0 | 10/9/2025 |
| Gregory A. Firestone | ▼ Sell | Tax Withholding | 1,093 | $2K | 8/3/2025 |
| Jeffrey Blizard | ▲ Buy | Grant | 104,800 | $0 | 6/2/2025 |
| Douglas G. Evans | ▲ Buy | Grant | 7,950 | $0 | 5/28/2025 |
| Federica F. O'Brien | ▲ Buy | Grant | 7,950 | $0 | 5/28/2025 |
| Kurt Azarbarzin | ▲ Buy | Grant | 7,950 | $0 | 5/28/2025 |
| Jeffrey Blizard | ▲ Buy | Grant | 7,950 | $0 | 5/28/2025 |
| Vincent J. Burgess | ▲ Buy | Grant | 7,950 | $0 | 5/28/2025 |
| Lisa N. Colleran | ▲ Buy | Grant | 7,950 | $0 | 5/28/2025 |
| Paul Talmo | ▼ Sell | Tax Withholding | 190 | $232 | 3/31/2025 |
| Megan Smeykal | ▼ Sell | Tax Withholding | 96 | $117 | 3/31/2025 |
| Antony Koblish | ▼ Sell | Tax Withholding | 384 | $468 | 3/31/2025 |
| Gregory A. Firestone | ▼ Sell | Tax Withholding | 119 | $145 | 3/31/2025 |
| Gregory A. Firestone | ▼ Sell | Tax Withholding | 240 | $636 | 2/24/2025 |
| Antony Koblish | ▼ Sell | Tax Withholding | 5,772 | $15K | 2/24/2025 |
| Paul Talmo | ▼ Sell | Tax Withholding | 1,049 | $3K | 2/24/2025 |
| Megan Smeykal | ▼ Sell | Tax Withholding | 539 | $1K | 2/24/2025 |
| Antony Koblish | ▼ Sell | Tax Withholding | 11,631 | $32K | 2/23/2025 |
| Roberto Cuca | ▼ Sell | Tax Withholding | 5,234 | $14K | 2/23/2025 |
| Gregory A. Firestone | ▼ Sell | Tax Withholding | 1,352 | $4K | 2/23/2025 |
| Paul Talmo | ▼ Sell | Tax Withholding | 4,061 | $11K | 2/23/2025 |
| Megan Smeykal | ▼ Sell | Tax Withholding | 423 | $1K | 2/23/2025 |
| Gregory A. Firestone | ▼ Sell | Tax Withholding | 364 | $990 | 2/21/2025 |
| Antony Koblish | ▲ Buy | Grant | 149,000 | $0 | 2/21/2025 |
| Gregory A. Firestone | ▲ Buy | Grant | 51,600 | $0 | 2/21/2025 |
| Paul Talmo | ▲ Buy | Grant | 38,100 | $0 | 2/21/2025 |
| Roberto Cuca | ▲ Buy | Grant | 57,000 | $0 | 2/21/2025 |
| Megan Smeykal | ▼ Sell | Tax Withholding | 1,590 | $4K | 2/21/2025 |
| Megan Smeykal | ▲ Buy | Grant | 9,400 | $0 | 2/19/2025 |
| Roberto Cuca | ▲ Buy | Open Market | 64,444 | $145K | 10/24/2024 |
| Paul Talmo | ▲ Buy | Open Market | 22,222 | $50K | 10/24/2024 |
| Antony Koblish | ▲ Buy | Open Market | 88,888 | $200K | 10/24/2024 |
| Gregory A. Firestone | ▲ Buy | Open Market | 6,666 | $15K | 10/24/2024 |
| Gregory A. Firestone | ▼ Sell | Tax Withholding | 1,093 | $5K | 8/3/2024 |
| ORBIMED ADVISORS LLC | ▼ Sell | Open Market | 36,600 | $166K | 7/2/2024 |
| ORBIMED ADVISORS LLC | ▼ Sell | Open Market | 13,700 | $64K | 7/1/2024 |
| ORBIMED ADVISORS LLC | ▼ Sell | Open Market | 378,000 | $1.8M | 6/28/2024 |
| Kurt Azarbarzin | ▲ Buy | Grant | 4,250 | $0 | 6/4/2024 |
| Jeffrey Blizard | ▲ Buy | Grant | 6,375 | $0 | 6/4/2024 |
| Vincent J. Burgess | ▲ Buy | Grant | 4,250 | $0 | 6/4/2024 |
| Federica F. O'Brien | ▲ Buy | Grant | 4,250 | $0 | 6/4/2024 |
| Douglas G. Evans | ▲ Buy | Grant | 4,250 | $0 | 6/4/2024 |
| Lisa N. Colleran | ▲ Buy | Grant | 4,250 | $0 | 6/4/2024 |
| Paul Talmo | ▼ Sell | Tax Withholding | 190 | $1K | 3/31/2024 |
| Antony Koblish | ▼ Sell | Tax Withholding | 385 | $2K | 3/31/2024 |
| Megan Smeykal | ▼ Sell | Tax Withholding | 96 | $544 | 3/31/2024 |
| Gregory A. Firestone | ▼ Sell | Tax Withholding | 119 | $675 | 3/31/2024 |
| Murphy Peter C. | ▼ Sell | Tax Withholding | 163 | $924 | 3/31/2024 |
| Megan Smeykal | ▼ Sell | Tax Withholding | 539 | $4K | 2/24/2024 |
| Antony Koblish | ▼ Sell | Tax Withholding | 5,726 | $40K | 2/24/2024 |
| Paul Talmo | ▼ Sell | Tax Withholding | 1,049 | $7K | 2/24/2024 |
| Murphy Peter C. | ▼ Sell | Tax Withholding | 940 | $7K | 2/24/2024 |
| Gregory A. Firestone | ▼ Sell | Tax Withholding | 240 | $2K | 2/24/2024 |
| Roberto Cuca | ▲ Buy | Grant | 29,200 | $0 | 2/23/2024 |
| Roberto Cuca | ▼ Sell | Tax Withholding | 2,785 | $20K | 2/23/2024 |
| Antony Koblish | ▼ Sell | Tax Withholding | 5,014 | $35K | 2/23/2024 |
| Antony Koblish | ▲ Buy | Grant | 77,500 | $0 | 2/23/2024 |
| Megan Smeykal | ▼ Sell | Tax Withholding | 423 | $3K | 2/23/2024 |
| Paul Talmo | ▲ Buy | Grant | 16,700 | $0 | 2/23/2024 |
| Paul Talmo | ▼ Sell | Tax Withholding | 2,577 | $18K | 2/23/2024 |
| Murphy Peter C. | ▲ Buy | Grant | 13,200 | $0 | 2/23/2024 |
| Murphy Peter C. | ▼ Sell | Tax Withholding | 2,315 | $16K | 2/23/2024 |
| Gregory A. Firestone | ▲ Buy | Grant | 15,000 | $0 | 2/23/2024 |
| Gregory A. Firestone | ▼ Sell | Tax Withholding | 240 | $2K | 2/23/2024 |
| Megan Smeykal | ▲ Buy | Grant | 9,400 | $0 | 2/21/2024 |
| Gregory A. Firestone | ▼ Sell | Tax Withholding | 364 | $3K | 2/21/2024 |
| Megan Smeykal | ▼ Sell | Tax Withholding | 795 | $6K | 2/21/2024 |
| Gregory A. Firestone | ▲ Buy | Open Market | 2,600 | $15K | 12/5/2023 |
| Antony Koblish | ▲ Buy | Open Market | 11,000 | $50K | 11/14/2023 |
| Roberto Cuca | ▲ Buy | Open Market | 10,000 | $45K | 11/14/2023 |
| Gregory A. Firestone | ▲ Buy | Grant | 17,950 | $0 | 8/3/2023 |
| Nosenzo John | ▲ Buy | Grant | 3,135 | $0 | 6/1/2023 |
| Douglas G. Evans | ▲ Buy | Grant | 3,135 | $0 | 6/1/2023 |
| Kurt Azarbarzin | ▲ Buy | Grant | 3,135 | $0 | 6/1/2023 |
| Federica F. O'Brien | ▲ Buy | Grant | 3,135 | $0 | 6/1/2023 |
| Vincent J. Burgess | ▲ Buy | Grant | 3,135 | $0 | 6/1/2023 |
| Lisa N. Colleran | ▲ Buy | Grant | 3,135 | $0 | 6/1/2023 |
| ORBIMED ADVISORS LLC | ▼ Sell | Open Market | 27,700 | $261K | 4/21/2023 |
| ORBIMED ADVISORS LLC | ▼ Sell | Open Market | 28,300 | $267K | 4/20/2023 |
| ORBIMED ADVISORS LLC | ▼ Sell | Open Market | 136,000 | $1.3M | 4/19/2023 |
| Paul Talmo | ▼ Sell | Tax Withholding | 187 | $2K | 3/31/2023 |
| Antony Koblish | ▼ Sell | Tax Withholding | 385 | $4K | 3/31/2023 |
| Megan Smeykal | ▼ Sell | Tax Withholding | 96 | $1K | 3/31/2023 |
| Murphy Peter C. | ▼ Sell | Tax Withholding | 163 | $2K | 3/31/2023 |
| Vincent J. Burgess | ▲ Buy | Option Exercise | 4,860 | $22K | 3/29/2023 |
| Murphy Peter C. | ▼ Sell | Tax Withholding | 940 | $10K | 2/24/2023 |
| Paul Talmo | ▼ Sell | Tax Withholding | 1,032 | $11K | 2/24/2023 |
| Antony Koblish | ▼ Sell | Tax Withholding | 6,034 | $67K | 2/24/2023 |
| Megan Smeykal | ▼ Sell | Tax Withholding | 539 | $6K | 2/24/2023 |
| Megan Smeykal | ▼ Sell | Tax Withholding | 423 | $4K | 2/23/2023 |
| Murphy Peter C. | ▲ Buy | Grant | 16,800 | $0 | 2/23/2023 |
| Roberto Cuca | ▼ Sell | Tax Withholding | 1,300 | $14K | 2/23/2023 |
| Murphy Peter C. | ▼ Sell | Tax Withholding | 906 | $10K | 2/23/2023 |
| Paul Talmo | ▼ Sell | Tax Withholding | 1,067 | $11K | 2/23/2023 |
| Antony Koblish | ▲ Buy | Grant | 61,200 | $0 | 2/23/2023 |
| Roberto Cuca | ▲ Buy | Grant | 17,700 | $0 | 2/23/2023 |
| Paul Talmo | ▲ Buy | Grant | 16,800 | $0 | 2/23/2023 |
| Megan Smeykal | ▲ Buy | Grant | 9,400 | $0 | 2/21/2023 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 19,000 | $148K | 11/3/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 1,262 | $10K | 11/3/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 15,000 | $120K | 10/11/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 1,000 | $8K | 10/11/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 304 | $2K | 9/23/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 6,500 | $52K | 9/23/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 1,000 | $8K | 9/19/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 17,000 | $137K | 9/19/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 2,000 | $16K | 9/16/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 372 | $3K | 9/16/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 658 | $5K | 9/15/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 3,500 | $28K | 9/15/2022 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | ▲ Buy | Open Market | 500,000 | $4.0M | 8/17/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 5,000 | $40K | 8/16/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 221 | $2K | 8/16/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 300,000 | $2.4M | 8/16/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 15,000 | $120K | 8/16/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 479 | $4K | 8/10/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 11,500 | $98K | 8/10/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 479 | $4K | 8/1/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 4,500 | $36K | 8/1/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 200 | $2K | 7/22/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 5,000 | $40K | 7/22/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 9,500 | $76K | 7/21/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 833 | $7K | 7/21/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 4,500 | $36K | 7/20/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 600 | $5K | 7/20/2022 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | ▲ Buy | Open Market | 5,000 | $40K | 7/14/2022 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | ▲ Buy | Open Market | 5,000 | $40K | 7/13/2022 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | ▲ Buy | Open Market | 5,000 | $40K | 7/12/2022 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | ▲ Buy | Open Market | 5,000 | $40K | 7/11/2022 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | ▲ Buy | Open Market | 5,000 | $40K | 7/8/2022 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | ▲ Buy | Open Market | 5,000 | $40K | 7/7/2022 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | ▲ Buy | Open Market | 5,000 | $39K | 7/6/2022 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | ▲ Buy | Open Market | 5,000 | $38K | 7/5/2022 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | ▲ Buy | Open Market | 5,000 | $36K | 7/1/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 200 | $1K | 7/1/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 567 | $4K | 6/30/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 2,998 | $21K | 6/30/2022 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | ▲ Buy | Open Market | 5,000 | $35K | 6/30/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 2 | $14 | 6/29/2022 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | ▲ Buy | Open Market | 5,000 | $35K | 6/28/2022 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | ▲ Buy | Open Market | 5,000 | $36K | 6/28/2022 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | ▲ Buy | Open Market | 5,000 | $36K | 6/27/2022 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | ▲ Buy | Open Market | 5,000 | $35K | 6/24/2022 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | ▲ Buy | Open Market | 5,000 | $35K | 6/23/2022 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | ▲ Buy | Open Market | 5,000 | $32K | 6/22/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 50,000 | $325K | 6/22/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 2,000 | $14K | 6/22/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 400 | $3K | 6/22/2022 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | ▲ Buy | Open Market | 5,000 | $31K | 6/21/2022 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | ▲ Buy | Open Market | 5,000 | $31K | 6/17/2022 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | ▲ Buy | Open Market | 5,000 | $30K | 6/16/2022 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | ▲ Buy | Open Market | 5,000 | $30K | 6/15/2022 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | ▲ Buy | Open Market | 5,000 | $29K | 6/14/2022 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | ▲ Buy | Open Market | 5,000 | $29K | 6/13/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 2,400 | $16K | 6/10/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 2,500 | $14K | 6/10/2022 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | ▲ Buy | Open Market | 5,000 | $29K | 6/10/2022 |
| Opaleye Management Inc. | ▲ Buy | Open Market | 25,000 | $140K | 6/10/2022 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | ▲ Buy | Open Market | 5,000 | $31K | 6/9/2022 |
| EW HEALTHCARE PARTNERS FUND 2, L.P. | ▲ Buy | Open Market | 5,000 | $30K | 6/8/2022 |
| Roberto Cuca | ▲ Buy | Open Market | 15,000 | $83K | 6/7/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Craig-Hallum initiates coverage on TELA Bio with $2 target
Craig-Hallum has started tracking TELA Bio, assigning a price target of $2. This new analyst note aligns with the current average analyst target of $2.08. The stock is currently trading above its 52-week low of $0.50, with recent technical indicators showing momentum near the upper end of its recent range.
Craig-Hallum initiates coverage on TELA Bio with $2 target. Craig-Hallum has started tracking TELA Bio, assigning a price target of $2. This new analyst note aligns with the current average analyst target of $2.08. The stock is currently trading above its 52-week low of $0.50, with recent technical indicators showing momentum near the upper end of its recent range.